publication date: Sep. 21, 2018

Senate passes conference bill, giving NIH $2 billion raise

By Matthew Bin Han Ong

The U.S. Senate Sept. 18 passed a conference “minibus” appropriations package that will increase the NIH budget by $2 billion to $39.1 billion—a 5.4 percent boost over the current level.

Of the proposed $2 billion, $190 million in new money would trickle down to NCI.

NCI is slated to receive $5.747 billion, of which up to $30 million may be used for facilities repairs and improvements at the NCI—Frederick Federally Funded Research and Development Center. The increase will bring NCI’s budget to a total of $6.1 billion, including $400 million in Moonshot funding.

The House is expected to pass the combined Defense, Labor-HHS appropriations package next week, well ahead of the end of the fiscal year.

“We urge the House to take quick action to pass this bill before the end of the fiscal year on September 30 and send it to the president for his signature,” Chris Hansen, president of the American Cancer Society Cancer Action Network, said in a statement. “There are very few legislative days left between now and then, but the lifesaving research taking place at NIH and across the country cannot wait.”

The last time the Senate passed nine appropriations bills on time was in 1999.

The conference report is the final product of negotiations between House and Senate appropriators as they attempt to merge their two disparate bills into one. The FY19 Defense, Labor-HHS package also includes a continuing resolution through Dec. 7 for any appropriations bills not enacted before Oct. 1.

“It’s a wonderful accomplishment that Congress and the president are now on the verge … Continue reading Senate passes conference bill, giving NIH $2 billion raise

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.